E R Bergert
Overview
Explore the profile of E R Bergert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice
Dwyer R, Bergert E, OConnor M, Gendler S, Morris J
Gene Ther
. 2005 Aug;
13(1):60-6.
PMID: 16121204
Ovarian cancer represents the fifth leading cause of cancer death among women in the United States, with >16 000 deaths expected this year. This study was carried out to investigate...
2.
Scholz I, Cengic N, Baker C, Harrington K, Maletz K, Bergert E, et al.
Gene Ther
. 2004 Oct;
12(3):272-80.
PMID: 15510175
We investigated the feasibility of using radioiodine therapy in colon carcinoma cells (HCT 116) following tumor-specific expression of the human sodium iodide symporter (hNIS) using the carcinoembryonic antigen (CEA) promoter....
3.
Dobert N, Hamscho N, Bergert E, Oeschger S, Berner U, Goellner J, et al.
Nuklearmedizin
. 2004 May;
42(4):N42-4.
PMID: 15127722
No abstract available.
4.
Spitzweg C, Scholz I, Bergert E, Tindall D, Young C, Goke B, et al.
Endocrinology
. 2003 Jul;
144(8):3423-32.
PMID: 12865321
We reported recently the induction of androgen-dependent iodide uptake activity in the human prostatic adenocarcinoma cell line LNCaP using a prostate-specific antigen (PSA) promoter-directed expression of the sodium iodide symporter...
5.
Pinke L, Dean D, Bergert E, Spitzweg C, Dutton C, Morris J
Thyroid
. 2001 Nov;
11(10):935-9.
PMID: 11716040
The iodide-concentrating ability of the thyroid gland is essential to the production of thyroid hormone. We report the nucleotide and amino acid sequence of the mouse sodium iodide symporter (mNIS),...
6.
Spitzweg C, Dietz A, OConnor M, Bergert E, Tindall D, Young C, et al.
Gene Ther
. 2001 Nov;
8(20):1524-31.
PMID: 11704812
Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of thyroid-specific expression of the sodium iodide symporter (NIS). Here we explore...
7.
Castro M, Bergert E, Goellner J, Hay I, Morris J
J Clin Endocrinol Metab
. 2001 Nov;
86(11):5627-32.
PMID: 11701745
The ability of thyroid cancers to concentrate radioiodine (RAI) is dependent, in part, upon the expression and functional integrity of the sodium iodide symporter (NIS). However, some differentiated thyroid carcinomas...
8.
Spitzweg C, Dutton C, Castro M, Bergert E, Goellner J, Heufelder A, et al.
Kidney Int
. 2001 Mar;
59(3):1013-23.
PMID: 11231356
Background: The human sodium iodide symporter (hNIS) is a transmembrane protein that mediates the active transport of iodide in the thyroid gland. Following cloning of NIS, NIS expression has been...
9.
Mitchell A, Manley S, Morris J, Powell K, Bergert E, Mortimer R
Placenta
. 2001 Feb;
22(2-3):256-8.
PMID: 11170832
The placenta must allow the passage of iodide from the maternal to the fetal circulation for synthesis of thyroxine by the fetal thyroid. The thyroid sodium iodide symporter (NIS) was...
10.
Spitzweg C, OConnor M, Bergert E, Tindall D, Young C, Morris J
Cancer Res
. 2000 Dec;
60(22):6526-30.
PMID: 11103823
Causing prostate cancer cells to express functionally active sodium iodide symporter (NIS) by targeted NIS gene transfer might offer the possibility of radioiodine therapy of prostate cancer. Therefore, we investigated...